Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram

Showing results (431-440 of 24,158) with videos related to

Pageof 2,416
Sort By:
ACS Medicinal Chemistry Letters|September 18, 2024
Novel Azepino[4,5-<i>b</i>]indolone as cGAS Inhibitors for Treating Immune-Mediated DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|September 18, 2024
Novel Triazolopyridine Derivatives as DGAT2 Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Pyrazolopyridine and Triazolopyridine Derivatives as DGAT2 Inhibitors for Treating Multiple DiseasesRam W Sabnis
Journal of Mid-Life Health|May 13, 2026
Virtual Reality and Digital Interventions in Cancer Pain Relief: A New Frontier in Supportive Oncology CareRam Kumar Garg
ACS Medicinal Chemistry Letters|December 17, 2025
Novel Compounds as PI3Kalpha Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|July 19, 2023
Nitrogen-Containing 2,3-Dihydroquinazolinone Compounds as Na<sub>v</sub>1.8 Inhibitors for Treating Pain and Cardiovascular DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|July 19, 2023
Fused Bicyclic Heteroaryl Compounds as NLRP3 Inhibitors for Treating Asthma or COPDRam W Sabnis
ACS Medicinal Chemistry Letters|June 14, 2023
Novel Quinoline Compounds as KRAS Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|June 14, 2023
Cyclopentathiophene Carboxamide Derivatives as PAFR Antagonists for Treating Ocular Diseases, Allergies, and Inflammation-Related DisordersRam W Sabnis
Endocrinology and Metabolism (Seoul, Korea)|April 16, 2026
Anabolics in Cancer Patients: To Use or Not to Use?A Ram Hong
Pageof 2,416

Showing results (431-440 of 24,158) with videos related to

Sort By:
Pageof 2,416
ACS Medicinal Chemistry Letters|September 18, 2024
Novel Azepino[4,5-<i>b</i>]indolone as cGAS Inhibitors for Treating Immune-Mediated DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|September 18, 2024
Novel Triazolopyridine Derivatives as DGAT2 Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Pyrazolopyridine and Triazolopyridine Derivatives as DGAT2 Inhibitors for Treating Multiple DiseasesRam W Sabnis
Journal of Mid-Life Health|May 13, 2026
Virtual Reality and Digital Interventions in Cancer Pain Relief: A New Frontier in Supportive Oncology CareRam Kumar Garg
ACS Medicinal Chemistry Letters|December 17, 2025
Novel Compounds as PI3Kalpha Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|July 19, 2023
Nitrogen-Containing 2,3-Dihydroquinazolinone Compounds as Na<sub>v</sub>1.8 Inhibitors for Treating Pain and Cardiovascular DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|July 19, 2023
Fused Bicyclic Heteroaryl Compounds as NLRP3 Inhibitors for Treating Asthma or COPDRam W Sabnis
ACS Medicinal Chemistry Letters|June 14, 2023
Novel Quinoline Compounds as KRAS Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|June 14, 2023
Cyclopentathiophene Carboxamide Derivatives as PAFR Antagonists for Treating Ocular Diseases, Allergies, and Inflammation-Related DisordersRam W Sabnis
Endocrinology and Metabolism (Seoul, Korea)|April 16, 2026
Anabolics in Cancer Patients: To Use or Not to Use?A Ram Hong
Pageof 2,416